Sources

7 Total Sources

FDA Approves Merck's Once-Daily Lipfendra Pill for LDL Reduction, Eyeing Billions in Sales

Left50%
Center33%
Right17%
The Guardian7d ago
Merck's Lipfendra: New Daily Pill Approved by FDA for High LDL Cholesterol
Bloomberg8d ago
Merck's Lipfendra Pill Receives FDA Approval for Cholesterol Reduction
The Wall Street Journal8d ago
Merck's Cholesterol Pill Lipfendra Approved, Ushering in New Wave of Treatment - WSJ
Reuters8d ago
Merck's cholesterol pill gets US FDA approval | Reuters
The New York Times8d ago
The F.D.A. Approves a New Pill to Slash Cholesterol Levels - The New York Times
WHTC8d ago
Merck's cholesterol pill gets US FDA approval | 1450 AM 99.7 FM WHTC | Holland
Marketscreener.com8d ago
Merck's LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia | MarketScreener